Asymchem Laboratories (Tianjin) Co., Ltd. Share Price OTC Markets
Stocks
ASLT.Y
US04651E1038
Pharmaceuticals
OTC Markets Traded| Market Cap | 60.16B 8.95B 7.68B 7.21B 6.58B 12.42B 854B 12.5B 85.15B 33.09B 431B 33.6B 32.87B 1,425B | P/E 2026 * |
45.5x | P/E 2027 * | 34.6x |
|---|---|---|---|---|---|
| Enterprise Value | 55.46B 8.25B 7.08B 6.64B 6.07B 11.45B 787B 11.52B 78.49B 30.5B 398B 30.97B 30.3B 1,314B | EV / Sales 2026 * |
6.86x | EV / Sales 2027 * | 5.77x |
| Free-Float |
61.13% | Yield 2026 * |
0.8% | Yield 2027 * | 1.06% |
| Manager | Title | Age | Since |
|---|---|---|---|
Hao Hong
CEO | Chief Executive Officer | 70 | 06/10/1998 |
Rui Yang
CEO | Chief Executive Officer | 49 | 18/01/2022 |
Elut Hsu
PSD | President | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Rui Yang
BRD | Director/Board Member | 49 | 17/07/2011 |
Hao Hong
CHM | Chairman | 70 | 06/10/1998 |
Ye Song
BRD | Director/Board Member | 65 | 17/07/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 8.96B | |
| -3.59% | -2.96% | +71.06% | +114.83% | 1,100B | |
| -1.15% | -0.41% | +51.34% | +62.41% | 658B | |
| -1.09% | +1.54% | +26.67% | +79.22% | 470B | |
| -1.47% | +2.05% | +41.71% | +42.09% | 372B | |
| -0.90% | +1.29% | +25.62% | +41.75% | 304B | |
| -1.94% | +1.53% | +3.05% | +13.24% | 264B | |
| -0.43% | +3.54% | +52.65% | +71.75% | 239B | |
| -0.93% | +2.90% | -16.98% | -52.28% | 213B | |
| -0.46% | +3.24% | +29.73% | +92.67% | 184B | |
| Average | -1.20% | +3.01% | +31.65% | +51.74% | 422.54B | |
| Weighted average by Cap. | -1.82% | +2.21% | +42.86% | +68.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 8.09B 1.2B 1.03B 968M 884M 1.67B 115B 1.68B 11.44B 4.45B 57.98B 4.52B 4.42B 192B | 9.78B 1.46B 1.25B 1.17B 1.07B 2.02B 139B 2.03B 13.85B 5.38B 70.17B 5.47B 5.35B 232B |
| Net income | 1.36B 203M 174M 163M 149M 281M 19.32B 283M 1.93B 749M 9.76B 760M 744M 32.26B | 1.79B 267M 229M 215M 196M 370M 25.44B 372M 2.54B 986M 12.85B 1B 979M 42.47B |
| Net Debt | -4.71B -700M -601M -564M -515M -972M -66.81B -978M -6.66B -2.59B -33.76B -2.63B -2.57B -112B | -3.73B -554M -476M -446M -408M -769M -52.9B -774M -5.27B -2.05B -26.73B -2.08B -2.04B -88.31B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
